Previous Article | Next Article ![]()
Journal of Clinical Microbiology, January 1999, p. 179-188, Vol. 37, No. 1
Organon Teknika, Boxtel, The Netherlands
Received 29 June 1998/Returned for modification 7 August
1998/Accepted 13 October 1998
To identify single immunodominant marker proteins which can replace
complex virion antigen in serodiagnostic assays, we investigated in
detail the molecular fine specificity of antibody responses in
different individuals with latent or active human cytomegalovirus (HCMV) infection. An overview of the HCMV proteins recognized by human
antibodies was obtained by immunoblotting. For selected immunodominant
proteins the epitope fine specificity of the antibody response was
determined by a peptide-scanning enzyme-linked immunosorbent assay
(ELISA). Epitope clusters were synthesized as combination peptides and
were used for further serologic analysis of immunoglobulin M (IgM) and
IgG reactivities with panels of sera from different groups of patients
in comparison to those with cytomegalovirus (CMV) virion antigen.
Several serum samples had significantly higher reactivities with
peptides than with the CMV virion antigen. However, individual serum
samples occasionally recognized diverse peptide epitopes, stressing the
importance of using combinations of peptides in serologic assays. From
these studies we were able to define a specific combination of peptides
derived from pp52 (UL44) and pp150 (UL32) for the specific and highly
sensitive early detection of HCMV IgM, whereas a combination of
peptides from pp150 (UL32), gB (UL55), and pp28 (UL99) was selected to give optimal and specific reactivity with HCMV IgG. On the basis of the
results obtained with these peptide combinations, new, highly specific
serodiagnostic assays were constructed. These assays had sensitivities
of 98.9 and 96.4% for IgG and IgM, respectively, in comparison with
the results obtained with the "gold standard," the virion
antigen-based ELISA. From the results of this study we conclude that
specific combinations of highly defined synthetic peptides can replace
complex HCMV virion extracts used in current serodiagnostics and may
add to further standardization of HCMV serology.
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Molecular Fine-Specificity Analysis of Antibody
Responses to Human Cytomegalovirus and Design of Novel
Synthetic-Peptide-Based Serodiagnostic Assays
*
Corresponding author. Mailing address: Organon Teknika,
Boseind 15, 5281 RM Boxtel, The Netherlands. Phone: 31-411-654486. Fax:
31-411-654311. E-mail:
a.greijer{at}teknika.btl.akzonobel.nl.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|